- Page 3 and 4: CONTENTSCHIEF EXECUTIVE OFFICERS’
- Page 5 and 6: CHIEF EXECUTIVE OFFICERS’ MESSAGE
- Page 7 and 8: THE GUERBET GROUP1) History of the
- Page 9 and 10: 3) Business overview3.1 Guerbet is
- Page 11 and 12: 3.4 The pathologiesIn Oncology, the
- Page 13: Guerbet's offering of products is c
- Page 16 and 17: c) Research & development• R&D ob
- Page 18 and 19: • A proactive partnering strategy
- Page 20 and 21: 5) Group organisation at 31 Decembe
- Page 22 and 23: e) DistributionGuerbet distribute i
- Page 24 and 25: DirectorsOther offices and director
- Page 26 and 27: There exist no arrangements or unde
- Page 28 and 29: Summary of compensation for Marie-C
- Page 30 and 31: • Stock options granted to non-of
- Page 32 and 33: I - 1Organisation of the work of th
- Page 34 and 35: "Research and Innovation" Committee
- Page 36 and 37: II - Internal control and risk mana
- Page 40 and 41: SHAREHOLDER INFORMATION1) The Guerb
- Page 42 and 43: As at 31 December 2010SHARESVOTING
- Page 44 and 45: considered to have automatically re
- Page 46 and 47: 10) Provisions of the Articles of A
- Page 48 and 49: c) Earnings highlightsIFRS(in thous
- Page 50 and 51: g) OutlookStrongly focused on the n
- Page 52 and 53: 3) Risk factorsThe company conducte
- Page 54 and 55: • Sourcing risksGuerbet has an ex
- Page 56 and 57: • Information technology risksAn
- Page 58 and 59: • Five-year summary of consolidat
- Page 60 and 61: • Other information included in t
- Page 62 and 63: • Recruitment and dismissalsGuerb
- Page 64 and 65: and employee savings. The goal is s
- Page 66 and 67: • Measures adopted to promote emp
- Page 68 and 69: ) Pollution and waste managementThe
- Page 70 and 71: 3) Societal informationa) Territori
- Page 72 and 73: • Consolidated income statementIn
- Page 74 and 75: In thousands of euros• Statement
- Page 76 and 77: Changes in standards and interpreta
- Page 78 and 79: g) Research and development expendi
- Page 80 and 81: Held to maturity investmentsHeld-to
- Page 82 and 83: creation are recorded under "Other
- Page 84 and 85: III) Notes to the financial stateme
- Page 86 and 87: Aged trial balance information for
- Page 88 and 89:
2.2 - Borrowings by currencyCurrenc
- Page 90 and 91:
3.3 - Analysis of the sensitivity o
- Page 92 and 93:
Revenue2012European companiesfor th
- Page 94 and 95:
In 2005, the Group acquired for ¥5
- Page 96 and 97:
6.2 - Analysis of property, plant a
- Page 98 and 99:
The change in the net value of inve
- Page 100 and 101:
12.2 - Accrued employee benefitsa)
- Page 102 and 103:
Change in net liabilities of the pe
- Page 104 and 105:
14.4 - Personnel by region at year-
- Page 106 and 107:
Note 22 - Research and development
- Page 108 and 109:
Note 25 - Related parties25.1 - Rel
- Page 110 and 111:
Note 27 - Basic earnings per share
- Page 112 and 113:
2) Auditors’ report on the consol
- Page 114 and 115:
3) Parent company financial stateme
- Page 116 and 117:
• Income statementIn thousands of
- Page 118 and 119:
• Statement of cash flowsIn milli
- Page 120 and 121:
c) Property, plant and equipmentPro
- Page 122 and 123:
Note 1 - Intangible assets1 - 1 - C
- Page 124 and 125:
Note 6 - Receivables by maturityCos
- Page 126 and 127:
Note 9 - Regulated provisionsInvest
- Page 128 and 129:
Note 13 - Sales by region2012 2011F
- Page 130 and 131:
Tax income or expense recorded in t
- Page 132 and 133:
Debt waiver agreements granted to a
- Page 134 and 135:
Capital lease commitments relative
- Page 136 and 137:
4) Auditors' report on the separate
- Page 138 and 139:
5) Auditors' special report on rela
- Page 140 and 141:
ORDINARY AND EXTRAORDINARY GENERAL
- Page 142 and 143:
RESOLUTION THREE (Special report of
- Page 144 and 145:
Extraordinary resolutionsRESOLUTION
- Page 146 and 147:
3) Report of the Board of Directors
- Page 148 and 149:
Application of legal provisions gov
- Page 150 and 151:
• Tenth draft resolution: stock s
- Page 152 and 153:
2) The Statutory Auditorsa) Statuto
- Page 154 and 155:
6) Articles of association (selecte
- Page 156 and 157:
7) 2013 shareholders calendarEventD
- Page 158 and 159:
) Annual financial reportInformatio